ARTHRITIS AND RHEUMATISM, vol.50, no.7, pp.2191-2201, 2004 (SCI-Expanded)
Article / Article
ARTHRITIS AND RHEUMATISM
Science Citation Index Expanded (SCI-EXPANDED), Scopus
Istanbul University Affiliated:
Objective. To compare the safety and efficacy of parenteral methotrexate (MTX) at an intermediate dosage (15mg/m(2)/week) versus a higher dosage (30 mg/m(2)/ week) in patients with polyarticular-course juvenile idiopathic arthritis (JIA) who failed to improve while receiving standard dosages of MTX (8-12.5 mg/m(2)/ week).